Early High-Dose Vitamin D and Residual β-Cell Function in Pediatric Type 1 Diabetes
Status:
Not yet recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
The project aims to study the effect of early high-dose vitamin D supplementation on type 1
diabetes in children and adolescents receiving intensive insulin therapy. The results may
lead to major changes in the early treatment of type 1 diabetes, with special emphasis on the
use of vitamin D to improve the function of residual β-cells and maintain standardized
insulin therapy for these patients. The overall goal is to reduce the long-term complications
of type 1 diabetes.